Hartford Personal Injury Lawyer articles in category: FDA & Prescription Drugs

The maker of the widely used Ortho Evra birth control patch, Johnson & Johnson, is trying to prevent negative attention over its dangerous contraceptive by purchasing the rights to domain names like Orthoevrakills.com and Deathbypatch.com. In late 2005 when the Food and Drug Administration urged that a heightened warning alerting users to the risk of potentially fatal blood clot and stroke be...

The FDA announced that the maker of the Parkinson's disease drug Permax was voluntarily withdrawing the medication because of the risk of serious damage to patients' heart valves. Permax increases the chance of regurgitation of the tricuspid, mitral and aortic valves of the heart.

Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to higher chance of heart attack, stroke and worsening heart chest pain that can become a heart attack, U.S. government health officials said Friday. Novartis agreed to withdraw Zelnorm at the FDA's requestZelnorm, also called tegaserod maleate, is a prescription medication approved for...

Last January the FDA issued a block box warning for the topical ointments Protopic and Elidel. The warning was issued due to long-term use of the drugs possibly being linked to cancer.

A personal injury lawsuit has been filed in Santa Clara County Court against a Mountain View company and others involved in developing the Ortho Evra patch, a widely used contraceptive that has been the source of thousands of adverse reaction complaints around the country. The latest lawsuit names 46 plaintiffs -- the majority of them young women in their teens and 20s -- who suffered blood...

The F.D.A. announced that Bayer A.G., failed to reveal to federal drug officials the results of a large study suggesting that Trasylol might increase the risks of death and stroke. The F.D.A. recently announced that Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes.The F.D.A. only found out about the Trasylol study after getting a tip from a...

An investigation by the Associated Press revealed birth control patch users die and suffer blood clots at a rate three times higher than women taking the pill. It is believe that this serious increase risk is connected to the fact that the birth control patch delivers about 60% more estrogen than the pill.

Accoring to a new analysis of 19 studies, popular asthma medicines such as Advair and Serevent pose a substantially increased risk of hospitalization and death to users compared with placebos. This new analysis raises the possibility that the drug should be taken off the market if it continues to be so widely used.The Washington Post quoted the lead author of the new analysis, Shelley Salpeter...

Documents have surfaced showing that Ortho-McNeil, the manufacturer of the Ortho Evra birth-control patch and subsidiary of Johnson & Johnson, refused in 2003 to fund a study comparing the Ortho patch to the company's Ortho-Cyclen pill because there was too high of chance that the study may not produce a positive result for the patch. In November of 2005, the FDA warned that women using the...

Vioxx admitted that its statistical analysis test does not support the company's 18-month theory about Vioxx.Since pulling Vioxx from the market, Merck has argued that only continuous use of VIoxx for over 18-months can lead to heart problems. The company cited to its 2005 statistical test results to support its theory. Now Merck admits that the test was wrong. This admissions only fuels what...